Some Topical Aspects of the "Sports Heart" Problem (Literature Review). Part I

Alexander V Korotkikh1, Julia V Vakhnenko1, Maksim G Kashtanov2

  • 1Cardiac Surgery Clinic, Amur State Medical Academy, Blagoveshchensk, Russia.

PubMed

Insights

Elite athletes may experience pathological heart remodeling, detectable via echocardiography. Identifying these changes is crucial for preventing sudden cardiac death and guiding training eligibility.

Area of Science:

  • Sports Cardiology
  • Cardiovascular Physiology
  • Exercise Medicine

Background:

  • Elite athletes' cardiovascular systems face significant overload, leading to morphological and functional changes.
  • Some athletes develop nonadaptive (pathological) cardiac remodeling, distinct from normal training adaptations.
  • This pathological remodeling can manifest as cardiac hypertrophy, dilatation, or hypertension, impacting athletic participation.

Purpose of the Study:

  • To review expert consensus on criteria for pathological cardiac remodeling in athletes.
  • To highlight the role of echocardiography in diagnosing these cardiac changes.
  • To discuss the implications for athlete health, including sudden cardiac death risk and training eligibility.

Main Methods:

  • Review of authoritative specialist views in sports medicine.
  • Analysis of echocardiography indicators for pathological remodeling.
  • Discussion of normal physiological responses versus pathological changes in blood pressure and cardiac structure.
  • Examination of causes of sudden cardiac death in athletes.
  • Exploration of genetic selection in sports.

Main Results:

  • Echocardiography provides objective features for identifying pathological cardiac remodeling.
  • Deviations from the norm (e.g., pronounced hypertrophy, hypertension) can indicate myocardial dysfunction.
  • Certain structural and electrical abnormalities are predictors of severe complications, including sudden cardiac death.
  • Distinguishing normal adaptation from pathological remodeling is critical for athlete management.

Conclusions:

  • Echocardiography is vital for diagnosing pathological cardiac remodeling in athletes.
  • Identifying nonadaptive changes is essential for preventing adverse cardiovascular events.
  • Clear criteria are needed to guide decisions on athlete training and competition admission.
  • Understanding pathological remodeling impacts the future of sports medicine and athlete selection.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
870
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
371
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
24
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
371
Anatomy of the Heart01:27

Anatomy of the Heart

The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
109.8K